Document is current
Any future updates will be listed below
-
Authors
Schramm, Sara http://orcid.org/0000-0001-6493-6009
Jokisch, Martha
Jöckel, Karl-Heinz
Herring, Arne
Keyvani, Kathy
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 7 October 2021
Accepted: 6 December 2021
First Online: 20 December 2021
Declarations
:
: This study was approved by the ethical commission of the Medical Faculty of the University Duisburg-Essen (AZ 99-69-1200).
: All participants gave informed written consent.
: SS, MJ, and KHJ have no competing interests.AH and KK are inventors on the Patent “Agents inhibiting Kallikrein-8 for use in the prevention or treatment of Alzheimer’s Disease”; Patent No. 3353214, issued by The European Patent Office on 22/07/2021.
